Breaking News

Next chapter for Biden's Cancer Moonshot; postpartum depression's toll on immigrant farmworkers

September 20, 2023
Mike Reddy for STAT

STAT+ | AI is coming to your dentist's office. Will it build trust, or erode it?

FDA-approved AI dental tools from Pearl, Videa and Overjet gaining use. Dentistry poised to be the fastest adopter of AI tech in health care.

By Casey Ross


Free Covid tests will be offered again to all U.S. households

The Biden administration is offering Covid tests to meet current needs, and to stimulate a testing industry that has faced cratering demand.

By Helen Branswell and Rachel Cohrs


A needle-free anaphylaxis treatment runs into an FDA roadblock

A nasal epinephrine spray called neffy, if approved, would present an alternative to EpiPens for people at risk of severe allergic reactions.

By Isabella Cueto



A study from Ziyad Al-Aly, clinical epidemiologist at Washington University in St. Louis, showed that vaccination appears to lower, but not eliminate, the risk of long Covid.
Courtesy Matt Miller/Washington University

Does the risk of getting long Covid increase each time you get reinfected?

Do odds of getting long Covid go up with more coronavirus infections? It's "clear in our data that reinfection contributes additional risk."

By Elizabeth Cooney


STAT+ | The Apellis eye drug rebound accelerates. This time, it's a competitor falling behind

In market battle of drugs for a common type of vision loss, Syfovre by Apellis gains upper hand as questions linger on Astellas' Izervay.

By Adam Feuerstein


STAT+ | Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro

The move comes as more Americans clamor for medicines to lose weight, causing shortages and boosting sales of compounded versions.

By Ed Silverman


Adobe

Researchers use AI to measure recovery from treatment-resistant depression

Using brain scans, researchers measured recovery from treatment-resistant depression — a crucial step toward objectively tracking recovery.

By Mohana Ravindranath


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments